We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+12.08%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$4.83B
AUM Growth
-$49M
Cap. Flow
-$540M
Cap. Flow %
-11.18%
Top 10 Hldgs %
39.24%
Holding
97
New
19
Increased
18
Reduced
23
Closed
18

Sector Composition

Rank Sector Weight
1 Communication Services 17.34%
2 Consumer Discretionary 16.67%
3 Industrials 13.18%
4 Real Estate 10.86%
5 Healthcare 10.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EDU icon
51
New Oriental
EDU
$8.88B
$15.8M 0.33%
500,000
OCIP
52
DELISTED
OCI Partners LP
OCIP
$13.8M 0.29%
+500,000
New +$11.9M
RPRX
53
DELISTED
Repros Therapeutics Inc.
RPRX
$12.8M 0.27%
700,000
+230,000
+49% +$4.34M
EIGI
54
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$10.6M 0.22%
+750,000
New +$9.56M
PCO
55
DELISTED
Pendrell Corporation - Class A
PCO
$9.98M 0.21%
4,964
+967
+24% +$1.99M
ANAC
56
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$9.44M 0.2%
562,352
+112,352
+25% +$1.55M
ASIA
57
DELISTED
ASIAINFO-LINKAGE INC COM STK (DE)
ASIA
$9.39M 0.19%
785,300
+757,638
+2,739% +$8.86M
OREX
58
DELISTED
Orexigen Therapeutics, Inc.
OREX
$9.04M 0.19%
160,500
+65,500
+69% +$3.68M
NKTR icon
59
Nektar Therapeutics
NKTR
$2.53B
$6.92M 0.14%
40,667
HZNP
60
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$6.32M 0.13%
829,420
-1,393,651
-63% -$7.52M
TTM
61
DELISTED
Tata Motors Limited
TTM
$6.08M 0.13%
197,514
VIRX
62
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4.98M 0.1%
5,000
+1,595
+47% +$1.65M
CIM
63
Chimera Investment
CIM
$964M
$4.65M 0.1%
100,000
-53,667
-35% -$2.44M
OXFD
64
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$4.59M 0.1%
+237,000
New +$4.19M
MACK
65
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$4.3M 0.09%
102,356
NVGS icon
66
Navigator Holdings
NVGS
$1.36B
$4.04M 0.08%
+150,000
New +$3.49M
FATE icon
67
Fate Therapeutics
FATE
$279M
$3.42M 0.07%
+544,243
New +$3.43M
ARQL
68
DELISTED
Arqule Inc
ARQL
$3.15M 0.07%
1,464,699
DVAX
69
DELISTED
Dynavax Technologies
DVAX
$1.96M 0.04%
+100,000
New +$1.46M
STML
70
DELISTED
Stemline Therapeutics, Inc.
STML
$1.86M 0.04%
95,000
+36,000
+61% +$961K
CF icon
71
CF Industries
CF
$19.6B
$1.66M 0.03%
+35,530
New +$1.55M
BRX icon
72
Brixmor Property Group
BRX
$8.99B
$1.52M 0.03%
+75,000
New +$1.51M
PACT
73
DELISTED
PACTERA TECHNOLOGY INTL LTD SPONSORED ADR
PACT
$1.16M 0.02%
162,809
-997,191
-86% -$6.87M
KIN
74
DELISTED
Kindred Biosciences, Inc.
KIN
$918K 0.02%
+82,445
New +$983K
RCPT
75
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$290K 0.01%
+10,000
New +$268K

Similar funds

Thomas Steyer's Q4 2013 Portfolio in Review

As of Q4 2013, Thomas Steyer held 97 positions worth $4.83B, down 1% from $4.88B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Thomas Steyer withdrew a net $540M in Q4 2013, closing 18 positions and reducing 23 holdings. Its most notable exit was DELL INC, an estimated $369M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 17% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Thomas Steyer opened a new position in eBay worth $181M.

  • Thomas Steyer's largest Q4 2013 buy was eBay: 7,828,920 shares worth $181M.
  • Thomas Steyer added most to TIME WARNER CABLE INC NEW COM STK in Q4 2013, an estimated $237M increase.
  • Thomas Steyer's biggest Q4 2013 reduction was Charter Communications, cutting an estimated $74.3M.
  • Thomas Steyer fully exited DELL INC in Q4 2013, selling an estimated $369M.
  • Thomas Steyer's ten largest holdings make up 39% of its $4.83B portfolio in Q4 2013.
  • Thomas Steyer opened 19 new positions and closed 18 in Q4 2013.
  • Thomas Steyer's portfolio value fell 1% quarter-over-quarter to $4.83B.

Based on Farallon Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.